Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma. [electronic resource]
- Allergy 05 2020
- 1058-1068 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
1398-9995
10.1111/all.14268 doi
Adult Anti-Asthmatic Agents--adverse effects Antibodies, Monoclonal, Humanized Asthma--drug therapy Biological Products--therapeutic use Child Humans Quality of Life